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Epidemiology of diphtheria in the southwestern Indian 
Ocean is poorly documented. We analyzed 14 cases of in-
fection with toxigenic Corynebacterium diphtheriae reported 
during 2007–2015 in Mayotte, a French department located 
in this region. Local control of diphtheria is needed to mini-
mize the risk for importation of the bacterium into disease-
free areas.
Diphtheria due to toxigenic Corynebacterium diphthe-riae occurs sporadically across Europe, mostly in per-
sons who emigrated from disease-endemic countries (1,2). 
Systemic toxic effects occur in cutaneous diphtheria but 
less commonly than in pharyngeal or laryngeal diphtheria. 
C. diphtheriae is a well-recognized cause of chronic, non-
healing skin ulcers in the tropics (3,4). In France, diphthe-
ria has been a reportable disease since 1945. A vaccination 
program began in the late 1940s; no cases were reported 
during 1990–2001, and 13 cases were reported, all in visi-
tors or immigrants to France, since 2002. However, the epi-
demiology of diphtheria in the southwestern Indian Ocean 
region, where several French departments are located, is 
poorly documented.
Mayotte, a French department, is an island of the 
Comoros archipelago (Figure) and an attractive destina-
tion for migrants from the area. In 2012, Mayotte had 
212,645 inhabitants, at least 40% foreign born (5). We 
analyzed all cases of infection with toxigenic C. diph-
theriae reported in Mayotte since 2007 to evaluate the 
potential risk for dissemination of diphtheria inside and 
outside this area.
During 2007–2015, local hospitals reported 14 cases 
of toxigenic C. diphtheriae infection to the local health 
authorities: 1 case in an infant with severe respiratory 
symptoms who died from multiple organ failure and 13 
cutaneous diphtheria cases in patients who survived. Most 
of the patients (11/14) were male, and the median age was 
11 years (range 2 months–39 years). Eight patients had 
recently (most within 1 month) emigrated from neighbor-
ing islands.
Patients’ medical history was usually unknown, but 
vaccination status was available for 12 patients: 7 had re-
ceived >3 doses of diphtheria vaccine according to the vac-
cination schedule of France (6) and 5 were unvaccinated (the 
infant, 2 children, and 2 adults). All cutaneous infections 
occurred in patients with preexisting wounds. Eleven pa-
tients had chronic diphtheria infections (1–36 months) with 
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co-infections of other pathogens such as Staphylococcus 
aureus and Streptococcus pyogenes. All patients received 
antimicrobial drug therapy with surgical debridement if 
necessary. In the absence of signs of toxin dissemination, 
none of the patients with cutaneous diphtheria received 
diphtheria antitoxin. 
Diagnosis was established by isolation of C. diphthe-
riae and PCR detection of the toxin gene. All 14 isolates 
were sent to the National Reference Centre (Paris, France) 
to confirm the identification of the clinical isolates (all posi-
tive for C. diphtheriae tox gene), determine their biotypes 
(2 variant gravis and 12 variant mitis), and characterize 
their toxin production using the Elek test (positive for 9 
isolates). All isolates were sensitive to a large spectrum 
of antimicrobial drugs, except for fosfomycin. All inves-
tigations were conducted by local health authorities to 
implement control measures (throat swab specimens and 
antimicrobial prophylaxis of close contacts), according to 
national recommendations (7). Among 168 identified close 
contacts, we observed 8 asymptomatic respiratory carriers 
of toxigenic C. diphtheriae.
Poor health status and substandard living conditions 
are risk factors associated with transmission of diphtheria. 
Cutaneous diphtheria has been shown to be more conta-
gious than respiratory diphtheria (8). Furthermore, cuta-
neous diphtheria may be clinically indistinguishable from 
other common skin lesions in the tropics and underdiag-
nosed in cases of co-infection or confusion with the normal 
skin flora.
Due to its geographic location and given its low so-
cioeconomic status, the population of Mayotte remains 
exposed to diphtheria. Absence of widespread circu-
lation of toxigenic C. diphtheriae cannot be ruled out 
because of living conditions, the population’s difficul-
ties in accessing care, frequency of skin infections, and 
complexity of microbiological analyses of cutaneous 
samples. The high coverage for diphtheria vaccination 
in young children as estimated in a 2010 survey (95% 
for those 24–59 months of age) is likely to have contrib-
uted to the absence of respiratory cases and of systemic 
complications (9). Another possible explanation is that 
a high rate of skin infections caused by C. diphtheriae 
may result in early development or boosting of natural 
immunity against the disease (10).
Several elements are in favor of a persisting risk: 
pockets of nonvaccinated populations (many children and 
teenagers and most adults) in the local context of illegal 
immigration from neighboring countries pose a risk of se-
vere disease and of persistence of bacterium transmission. 
The finding that several isolates were producing the toxin 
is another element, as is the possibility of transmission 
from a cutaneous lesion to the throat of a close contact. 
Of note, >20 nontoxigenic isolates (in which PCRs did 
not detect the tox gene) were collected from cutaneous 
wounds during the same period. In accordance with na-
tional guidelines, no control measures were implemented 
around these cases.
Because human migrations across the area seem in-
evitable, improving sanitary conditions such as access to 
clean drinking water and maintaining high immunity levels 
in the population through vaccination are critical for local 
prevention and control of diphtheria. Use of these tools 
will minimize the risk of importation of C. diphtheriae into 
disease-free areas.
Dr. Belchior is a veterinary epidemiologist and expert in 
epidemiological surveillance of vaccine-preventable diseases at 
the French Public Health Agency (Santé publique France). He 
has been working on diphtheria for many years. Dr. Henry is a 
biologist and public health physician, working in particular in 
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Figure. Location of Mayotte in the southwestern Indian Ocean. 
Maps created by using IGN-GEOFLA (http://professionnels.ign.fr/
geofla) and Esri Data and Maps 10 http://www.esri.com/).
the Regional Health Agency Indian Ocean (ARS Océan Indien, 
Délégation de l’île de Mayotte). She has been working on 
infectious and tropical diseases for many years.
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Meningitis caused by Haemophilus influenzae type b (Hib) 
was eliminated in Oman after the introduction of Hib vaccine 
in 2001. However, a case of H. influenzae type a meningitis 
was diagnosed in a child from Oman in 2015, which high-
lights the need to monitor the incidence of invasive non-Hib 
H. influenzae disease.
Haemophilus influenzae can be encapsulated (serotypes a–f) or unencapsulated, nontypeable (NTHi) (1). By 
the end of 2014, all countries in the Eastern Mediterranean 
Region had introduced H. influenzae type b (Hib) vaccine 
into their immunization programs; in Oman, where it was 
introduced in 2001, it led to an elimination of Hib men-
ingitis (2,3). However, Hib vaccine does not cross-protect 
against other serotypes.
A previously healthy 17-month-old girl with G6PD 
deficiency was admitted to Nizwa Hospital, Nizwa, 
Oman, in August 2015 with a 1-day history of fever and 
lethargy and frequent vomiting and refusal of food for 
6–8 hours before admission. She had no history of rash, 
head trauma, drug ingestion, travel abroad, or contact 
with animals. Her vaccination record was up to date. Her 
3 older siblings were healthy. On examination, she was 
irritable and febrile (temperature 39°C), with tachypnea, 
tachycardia, and photophobia. On lung auscultation, a 
few crackles were heard on the right side. The rest of her 
physical examination, including a bedside undilated fun-
doscopic examination, was unremarkable. Blood tests, ce-
rebrospinal fluid examination, and neuroimaging studies 
were conducted (Table). Results of renal and liver func-
tion and metabolic screening tests and serum calcium, 
troponin T, immunoglobulins, and total complement lev-
els were within reference limits. Diagnostic test results 
were negative for respiratory viruses including influenza 
A(H1N1) and Middle East respiratory syndrome corona-
virus and for herpes simplex virus types 1 and 2. A chest 
radiograph showed right middle lobe haziness suggestive 
of pneumonitis.
The patient was treated with intravenous ceftriaxone. 
Blood culture revealed H. influenzae type a (Hia), which 
was serotyped by slide agglutination and determined to 
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